Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/mBio.01806-20 http://scihub22266oqcxt.onion/10.1128/mBio.01806-20 32769090!7419722!32769090     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32769090&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       mBio 2020 ; 11 (4): ? Nephropedia Template TP {{tp|p=32769090|t=2020. The Unrecognized Threat of Secondary Bacterial Infections with COVID-19 |pdf=|usr=}}{{32769090}} gab.com Text The Unrecognized Threat of Secondary Bacterial Infections with COVID-19 JO: mBio http://www.kidney.de/pget.php?&tw=1&pmid=32769090 #FOAvip Coronavirus disease 2019 (COVID-19) is the greatest pandemic of our generation, with 16 million people affected and 650,000 deaths worldwide so far. One of the risk factors associated with COVID-19 is secondary bacterial pneumonia. In recent studies on COVID-19 patients, secondary bacterial infections were significantly associated with worse outcomes and death despite antimicrobial therapies. In the past, the intensive use of antibiotics during the severe acute respiratory syndrome coronavirus (SARS-CoV) pandemic led to increases in the prevalence of multidrug-resistant bacteria. The rising number of antibiotic-resistant bacteria and our decreasing capacity to eradicate them not only render us more vulnerable to bacterial infections but also weaken us during viral pandemics. The COVID-19 pandemic reminds us of the great health challenges we are facing, especially regarding antibiotic-resistant bacteria. Twit Text FOAVip The Unrecognized Threat of Secondary Bacterial Infections with COVID-19 ????mBio http://www.kidney.de/pget.php?&tw=1&pmid=32769090 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32769090 #FOAvip English Wikipedia <ref>{{Cite pmid|32769090}}</ref> The Unrecognized Threat of Secondary Bacterial Infections with COVID-19 #MMPMID32769090 Vaillancourt M; Jorth P mBio 2020[Aug]; 11 (4): ? PMID32769090show ga Coronavirus disease 2019 (COVID-19) is the greatest pandemic of our generation, with 16 million people affected and 650,000 deaths worldwide so far. One of the risk factors associated with COVID-19 is secondary bacterial pneumonia. In recent studies on COVID-19 patients, secondary bacterial infections were significantly associated with worse outcomes and death despite antimicrobial therapies. In the past, the intensive use of antibiotics during the severe acute respiratory syndrome coronavirus (SARS-CoV) pandemic led to increases in the prevalence of multidrug-resistant bacteria. The rising number of antibiotic-resistant bacteria and our decreasing capacity to eradicate them not only render us more vulnerable to bacterial infections but also weaken us during viral pandemics. The COVID-19 pandemic reminds us of the great health challenges we are facing, especially regarding antibiotic-resistant bacteria. |*Bacterial Infections[MESH] |*Coronavirus[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |Adult[MESH] |Bacteria[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |China[MESH] |Coronavirus Infections/*epidemiology[MESH] |Humans[MESH] |Inpatients[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]The Unrecognized Threat of Secondary Bacterial Infections with COVID-1(epmc).pdf DeepDyve Pubget Overpricing